SARTOR, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 666
EU - Europa 248
AS - Asia 75
AF - Africa 4
SA - Sud America 3
OC - Oceania 1
Totale 997
Nazione #
US - Stati Uniti d'America 653
IT - Italia 63
FR - Francia 56
DE - Germania 37
IE - Irlanda 31
CN - Cina 21
AE - Emirati Arabi Uniti 12
BG - Bulgaria 12
VN - Vietnam 10
GB - Regno Unito 9
CA - Canada 7
ES - Italia 7
JP - Giappone 7
FI - Finlandia 5
IN - India 5
IR - Iran 5
MX - Messico 5
RU - Federazione Russa 5
AT - Austria 4
KR - Corea 4
TH - Thailandia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
RS - Serbia 3
BE - Belgio 2
CL - Cile 2
HK - Hong Kong 2
MA - Marocco 2
MK - Macedonia 2
NL - Olanda 2
TR - Turchia 2
UA - Ucraina 2
AU - Australia 1
BZ - Belize 1
CO - Colombia 1
GR - Grecia 1
IL - Israele 1
NO - Norvegia 1
SA - Arabia Saudita 1
SG - Singapore 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 997
Città #
Ashburn 93
Fairfield 54
Santa Cruz 50
Seattle 35
Woodbridge 32
Dublin 31
Buffalo 27
Houston 23
Bologna 17
Chicago 17
Boardman 15
Cambridge 14
Mountain View 14
Wilmington 13
Las Vegas 12
Sofia 12
Bremen 11
Dong Ket 9
New York 9
Ann Arbor 8
Waltham 7
Beijing 6
Columbus 6
Dallas 6
Ottawa 6
Paris 6
Southend 6
Cuauhtemoc 5
Los Angeles 5
Qom 5
San Diego 5
Atlanta 4
Bangkok 4
Barcelona 4
Clearwater 4
Fabriano 4
Helsinki 4
Saint Petersburg 4
Shanghai 4
Vienna 4
Boston 3
El Cerrito 3
Forlì 3
Francofonte 3
Milan 3
Munich 3
Secaucus 3
Tokyo 3
Washington 3
Ankara 2
Basking Ridge 2
Bellaria-Igea Marina 2
Brockport 2
Casablanca 2
Comano 2
Frankfurt Am Main 2
Gangnam-gu 2
Geel 2
Genoa 2
Hangzhou 2
Henderson 2
Lincoln 2
Milpitas 2
Narón 2
Novi Sad 2
Phoenix 2
Pieve di Cento 2
Portland 2
Pune 2
Redmond 2
Reggio Emilia 2
Rimini 2
Riva 2
Rome 2
Silver Spring 2
Skopje 2
Abbotsford 1
Amsterdam 1
Anklam 1
Bagnacavallo 1
Bari 1
Bloomfield 1
Bogotá 1
Brooklyn 1
Bryn Mawr 1
Cagliari 1
Carmel 1
Cedar Knolls 1
Central 1
Chandler 1
Changwon 1
Como 1
Coraopolis 1
Council Bluffs 1
Crema 1
Crugers 1
Dearborn 1
Decatur 1
Düsseldorf 1
Essen 1
Totale 700
Nome #
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia, file e1dcb332-f750-7715-e053-1705fe0a6cc9 108
The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report, file e1dcb330-5d38-7715-e053-1705fe0a6cc9 93
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file e1dcb338-c510-7715-e053-1705fe0a6cc9 84
Recurrent gastrointestinal hemorrhage in treatment with dasatinib in a patient showing SMAD4 mutation with acute lymphoblastic leukemia Philadelphia positive and juvenile polyposis hereditary hemorrhagic telangiectasia syndrome, file e1dcb332-7731-7715-e053-1705fe0a6cc9 83
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia, file e1dcb334-1481-7715-e053-1705fe0a6cc9 83
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia, file e1dcb335-710d-7715-e053-1705fe0a6cc9 77
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients, file e1dcb335-fa56-7715-e053-1705fe0a6cc9 77
A case report of acute myeloid leukemia and neurofibromatosis 1, file e1dcb335-41fc-7715-e053-1705fe0a6cc9 72
Synergism through WEE1 and CHK1 inhibition in acute lymphoblastic leukemia, file e1dcb334-10fb-7715-e053-1705fe0a6cc9 69
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters, file e1dcb339-2ea1-7715-e053-1705fe0a6cc9 51
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia, file 28c3b0be-1b08-4d0e-bd03-e2c9e8d48222 46
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells, file e1dcb339-133c-7715-e053-1705fe0a6cc9 32
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia, file e1dcb338-75ea-7715-e053-1705fe0a6cc9 29
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters, file 9ef7d348-9e1e-402a-a275-71ad8d77e11f 24
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents, file d74327b8-400c-4f10-9f39-c15714745631 18
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study, file e1dcb338-4edb-7715-e053-1705fe0a6cc9 18
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases, file 11e3ddaf-42a3-45f5-9568-708677b17117 15
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia, file e1dcb337-384e-7715-e053-1705fe0a6cc9 14
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant, file e1dcb339-3ad2-7715-e053-1705fe0a6cc9 10
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia, file e1dcb336-df0c-7715-e053-1705fe0a6cc9 6
Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment, file e1dcb330-8860-7715-e053-1705fe0a6cc9 5
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells, file e1dcb339-bce2-7715-e053-1705fe0a6cc9 4
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file 6b91808a-89ec-451f-bcac-4bd100943c74 3
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study, file b387d513-c986-410c-810c-62ca0510fad6 3
Posterior reversible encephalopathy syndrome in a B-cell acute lymphoblastic leukemia young adult patient treated with a pediatric-like chemotherapeutic schedule, file e1dcb330-8b09-7715-e053-1705fe0a6cc9 2
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure, file 3905c69c-0fe8-4ca6-8965-d1d87a0ed15f 1
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis, file 44547b71-147a-4fd7-93db-0f72c542d773 1
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted, file 627ee662-ed79-4973-98c1-01e0759de48c 1
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia, file c03661a0-6d59-43e7-8bfd-9f7376be3098 1
null, file e1dcb32d-4ae3-7715-e053-1705fe0a6cc9 1
Totale 1.031
Categoria #
all - tutte 3.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020111 0 0 0 5 8 15 16 14 16 12 13 12
2020/2021145 11 17 14 11 8 15 9 10 15 6 19 10
2021/2022193 9 7 5 15 19 2 3 16 5 10 76 26
2022/2023327 2 13 61 49 24 23 20 22 38 22 44 9
2023/2024252 5 4 10 34 23 53 36 30 31 21 5 0
Totale 1.031